Porsolt expands with the acquisition of Fluofarma

11 February 2016

logo_porsoltPorsolt has acquired Fluofarma, a Bordeaux-based company focused on the provision of cell-based assays and in vitro screening services. The acquisition further expands Porsolt’s capabilities and services that can assist clients at earlier stages of their drug discovery programs.


Read the full press-release


To learn more about Porsolt